down arrow

Kineta, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US49461C1027
USD
0.34
0.05 (15.9%)

Jun 27

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

0.300.34

52 Week

0.181.15
Valuation
Technical
Day's Volume

CASH

360

Shareholding (Mar 2025)

FII

0.59%

Held by 7 FIIs

DII

96.27%

Held by 3 DIIs

Promoter

0.25%

How big is Kineta, Inc.?

22-Jun-2025

As of Jun 18, Kineta, Inc. has a market capitalization of 3.66 million, with net sales of 0.00 million and a net profit of -8.45 million over the latest four quarters. Shareholder's funds are at -12.03 million, and total assets are 1.02 million as of Dec 24.

As of Jun 18, Kineta, Inc. has a market capitalization of 3.66 million, classifying it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of Net Sales for the latest four quarters is 0.00 million, while the sum of Net Profit for the same period is -8.45 million.<BR><BR>As of Dec 24, the reporting period shows Shareholder's Funds at -12.03 million and Total Assets at 1.02 million.

Read More

What does Kineta, Inc. do?

22-Jun-2025

Kineta, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $2 million and a market cap of $3.66 million. Key metrics include a negative P/E ratio, no dividend yield, and a return on equity of 62.88%.

Overview:<BR>Kineta, Inc. operates in the Pharmaceuticals & Biotechnology industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot:<BR>- Net Profit: -2 Million (Quarterly Results - Mar 2025)<BR>- Market Cap: USD 3.66 Million (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: NA (Loss Making)<BR>- Industry P/E: NA<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: -0.11<BR>- Return on Equity: 62.88%<BR>- Price to Book: -0.27<BR><BR>Contact Details:<BR>Details: No Company Details Available<BR>Registrar Address: Not available.

Read More

Is Kineta, Inc. overvalued or undervalued?

25-Jun-2025

As of August 8, 2024, Kineta, Inc. is considered overvalued and has deteriorated to a "does not qualify" valuation grade due to negative financial ratios and a year-to-date stock decline of 27.18%, significantly underperforming compared to the S&P 500.

As of 8 August 2024, Kineta, Inc. has moved from a valuation grade of risky to does not qualify, indicating a significant deterioration in its financial standing. The company is currently assessed as overvalued given its negative ratios, including a Price to Book Value of -0.23 and an EV to EBIT of -0.50. Furthermore, the company's return on equity (ROE) is negative, reflecting ongoing financial challenges.<BR><BR>In comparison to its peers, Kineta's valuation metrics are notably poor. For instance, Rezolute, Inc. has a P/E ratio of -4.90, while SELLAS Life Sciences Group, Inc. shows a P/E of -5.74, both indicating similar struggles within the sector. The recent performance of Kineta's stock has also lagged significantly behind the S&P 500, with a year-to-date decline of 27.18% compared to a 2.44% gain for the index. Overall, these factors suggest that Kineta, Inc. is overvalued in its current state.

Read More

Is Kineta, Inc. technically bullish or bearish?

20-Sep-2025

As of June 18, 2025, Kineta, Inc. shows a mildly bearish trend with mixed technical indicators, having outperformed the S&P 500 in the short term but significantly underperformed over the past year.

As of 18 June 2025, the technical trend for Kineta, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by daily moving averages indicating a bearish sentiment, while weekly MACD and KST show a mildly bullish trend. Bollinger Bands present a mixed view with weekly being bullish and monthly mildly bearish. The Dow Theory indicates a mildly bullish weekly trend but is bearish on a monthly basis. <BR><BR>In terms of returns, Kineta has outperformed the S&P 500 over the past week and month, with returns of 15.70% and 13.16% respectively, but has significantly underperformed over longer periods, including a -41.04% return over the past year compared to the S&P 500's 17.14%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 5 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.11

stock-summary
Return on Equity

62.88%

stock-summary
Price to Book

-0.34

Revenue and Profits:
Net Sales:
(Quarterly Results - Mar 2025)
Net Profit:
-2 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
8.77%
0%
8.77%
6 Months
-15.98%
0%
-15.98%
1 Year
-41.04%
0%
-41.04%
2 Years
-86.5%
0%
-86.5%
3 Years
-80.46%
0%
-80.46%
4 Years
-97.18%
0%
-97.18%
5 Years
-99.83%
0%
-99.83%

Kineta, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is Kineta, Inc. technically bullish or bearish?

As of 18 June 2025, the technical trend for Kineta, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by daily moving averages indicating a bearish sentiment, while weekly MACD and KST show a mildly bullish trend. Bollinger Bands present a mixed view with weekly being bullish and monthly mildly bearish. The Dow Theory indicates a mildly bullish weekly trend but is bearish on a monthly basis. In terms of returns, Kineta has outperformed the S&P 500 over the past week and month, with returns of 15.70% and 13.16% respectively, but has significantly underperformed over longer periods, including a -41.04% return over the past year compared to the S&P 500's 17.14%....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-100.00%
EBIT Growth (5y)
13.24%
EBIT to Interest (avg)
-25.01
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.11
Sales to Capital Employed (avg)
1.10
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
16.98%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.23
EV to EBIT
-0.50
EV to EBITDA
-0.50
EV to Capital Employed
-0.38
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 4 Schemes (2.88%)

Foreign Institutions

Held by 7 Foreign Institutions (0.59%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is 0.00% vs 0.00% in Dec 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is 36.00% vs -38.89% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.00",
          "val2": "-2.50",
          "chgp": "20.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.60",
          "val2": "-2.50",
          "chgp": "36.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -100.00% vs 170.00% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -21.28% vs 77.80% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "5.40",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-13.50",
          "val2": "-15.70",
          "chgp": "14.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.30",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3.80",
          "val2": "1.60",
          "chgp": "-337.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-17.10",
          "val2": "-14.10",
          "chgp": "-21.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "-2,889.20%",
          "chgp": "288.92%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQstock-summary
Mar'25
Dec'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-2.00
-2.50
20.00%
Interest
0.10
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1.60
-2.50
36.00%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

QoQ Growth in quarter ended Mar 2025 is 0.00% vs 0.00% in Dec 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2025 is 36.00% vs -38.89% in Dec 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
5.40
-100.00%
Operating Profit (PBDIT) excl Other Income
-13.50
-15.70
14.01%
Interest
0.00
0.30
-100.00%
Exceptional Items
-3.80
1.60
-337.50%
Consolidate Net Profit
-17.10
-14.10
-21.28%
Operating Profit Margin (Excl OI)
0.00%
-2,889.20%
288.92%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -100.00% vs 170.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -21.28% vs 77.80% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Kineta, Inc. stock-summary
stock-summary
Kineta, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."